Medical Marijuana Market Projections

Cannabis (or Marijuana) has been in use since 5000 BC. The cannabis plant is a complex plant consisting of over 400 chemical entities, out of which over 100 are cannabinoids (CBD). CBDs are, at present, used to serve various medical purposes such as pain due to cancer, regulating seizures, healing bones, quickening recovery, calming down nerves, treating autism, addressing depression, and many more. <br><br>Over the past few years, there is some serious debate regarding the use of marijuana for medical purposes. Some of the countries have legalized marijuana for medical purposes. However, a majority of the other countries have strictly prohibited its use, fearing potential misuse. In the US also different states follow different rules.<br><br>At the global level, some of the major pharma and biotech companies are involved in exploring the potential use of cannabis for treating different ailments. Some of the key companies in the medical marijuana market include MedReleaf, Tetra Bio-Pharma, TO Pharmaceuticals, Corbus Pharmaceuticals, Therapix Biosciences, Arena Pharmaceuticals, Canbex Therapeutics, Daisy Pharma Opioid Venture, Tilray, One World Cannabis Ltd, Centrexion Therapeutics and others.<br><br>Clinical effectiveness, increasing inclination of people toward cannabis use, minimal adverse side effects, legalization of marijuana, and the number of pipeline products are some of the key factors which are expected to play a key role in driving the medical marijuana market forward in the coming years. <br><br>Source: https://blog.marketresearch.com/the-state-of-the-medical-marijuana-market-in-2020<br><br><br>

DelveInsight + Follow